Tamboli Ajim insider trades
Tamboli Ajim has filed 4 Form 4s with the SEC that we hold, for First Tracks Biotherapeutics, Inc. (TRAX) (Chief Financial Officer) and Monte Rosa Therapeutics, Inc. (GLUE) (Chief Financial Officer). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2022-03-02 and the latest 2026-05-14.
First Tracks Biotherapeutics, Inc. (TRAX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Monte Rosa Therapeutics, Inc. (GLUE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1855684) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms